Learn more about our Advocacy work.
The Advanced Medical Technology Association® (AdvaMed®), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from…
A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
The year-end spending package making its way through Congress includes key provisions championed by the Advanced Medical Technology Association® (AdvaMed®) that will benefit the patients served by the medical technology…
AdvaMed®, joined by American Cancer Society Cancer Action Network, The Pew Charitable Trust, Friends of Cancer Research, and other, sent a letter urging the leaders of the Senate Committee on Health,…
Today, the Advanced Medical Technology Association® (AdvaMed®) announced that Susan Askew has joined the association as PAC Director.
Today, the Advanced Medical Technology Association® (AdvaMed®) announced that Darbi Gottlieb has joined the Association’s state affairs team as director of state government and regional affairs.
In a RealClearHealth op-ed, AdvaMed® president and CEO Scott Whitaker outlines how the recently enacted medical device user fee agreement will help the FDA and medical technology innovators.
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
Lucy Fraiser, Ph.D., a board-certified toxicologist, recently responded in a letter to the editor of Modern Healthcare about the publication’s recent coverage of the EPA’s work on ethylene oxide.